FASTKD3
FAST kinase domain-containing protein 3, mitochondrial
Also known as: FAKD3_HUMAN, FLJ23274, MGC5297
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14CZ7
- Gene
- FASTKD3
- Ensembl
- ENSG00000124279
- Chromosome
- 5
- Canonical length
- 662 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
This gene encodes a member of a small family of Fas-activated serine/threonine kinase domain (FASTKD) containing proteins that share an amino terminal mitochondrial targeting domain and multiple carboxy terminal FAST domains as well as a putative RNA-binding RAP domain. The members of this family are ubiquitously expressed and are generally most abundant in mitochondria-enriched tissues such as heart, skeletal muscle and brown-adipose tissue. Some members of this protein family may play a role in apoptosis. The protein encoded by this gene interacts with components of the mitochondrial respiratory and translation networks. A pseudogene of this gene is also present on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
Canonical amino-acid sequenceUniProt
662 residues, UniProt reviewed canonical sequence.
>Q14CZ7|FASTKD3
1 MALITLRKNL YRLSDFQMHR ALAALKNKPL NHVHKVVKER LCPWLCSRQP EPFGVKFHHA
61 HCKKFHSKNG NDLHPLGGPV FSQVSDCDRL EQNVKNEESQ MFYRRLSNLT SSEEVLSFIS
121 TMETLPDTMA AGALQRICEV EKKDGDQGLP KEILENSIFQ ALCFQFEKEP SQLSNTSLVT
181 ALQALILLHV DPQSSLLLNL VAECQNRLRK GGMEVRNLCI LGESLITLHS SGCVTLELII
241 NQLQGEKLET FTPEDIVALY RILQACTEKV DEHQTFLNKI NNFSLSIVSN LSPKLISQML
301 TALVVLDQSQ AFPLIIKLGK YVVRHVPHFT NEELRRVLEA FIYFGHHDTF FTKALEHRVA
361 AVCLTLDPEV VCRVMEYCSR ELILSKPILN AVAETFVCQT EKFSPRQISA LMEPFGKLNY
421 LPPNASALFR KLENVLFTHF NYFPPKSLLK LLHSCSLNEC HPVNFLAKIF KPLFLQRLQG
481 KESHLDTLSR AQLTQLFLAS VLECPFYKGP KLLPKYQVKS FLTPCCSLET PVDSQLYRYV
541 KIGLTNLLGA RLYFAPKVLT PYCYTIDVEI KLDEEGFVLP STANEDIHKR IALCIDGPKR
601 FCSNSKHLLG KEAIKQRHLQ LLGYQVVQIP YHEIGMLKSR RELVEYLQRK LFSQNTVHWL
661 QELocalizationUniProt · AlphaFold · HPA
Whether an antibody against FASTKD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 8.4 nTPM
Expression across tissuesHPA
Tissue
- kidney: 8.4 nTPM
- liver: 6.2 nTPM
- rectum: 6.2 nTPM
- tonsil: 6.1 nTPM
- breast: 5.8 nTPM
- small intestine: 5.6 nTPM
Single-cell type
- paneth cells: 16 nCPM
- gastric progenitor cells: 14 nCPM
- decidual stromal cells: 13 nCPM
- megakaryocytes: 12 nCPM
- parietal cells: 12 nCPM
- erythrocyte progenitors: 12 nCPM
Immune cell
- T-reg: 8.2 nTPM
- memory B-cell: 7.8 nTPM
- naive CD4 T-cell: 7.2 nTPM
- naive CD8 T-cell: 6.8 nTPM
- memory CD4 T-cell: 6.7 nTPM
- MAIT T-cell: 6.1 nTPM
Brain region
- choroid plexus: 4.7 nTPM
- white matter: 4.3 nTPM
- cerebral cortex: 3.8 nTPM
- basal ganglia: 3.5 nTPM
- spinal cord: 3.4 nTPM
- hypothalamus: 3.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.81
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mitochondrial respiratory chain complex IV assembly
- mitochondrial RNA processing
- positive regulation of mitochondrial translation
- regulation of mitochondrial mRNA stability
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FASTKD3 as an antibody target. Whether an autoantibody or antibody against FASTKD3 could matter depends on whether native FASTKD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FASTKD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FASTKD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...